Aprea Therapeutics (APRE) has priced its initial public offering at the midpoint of its range, IPO Boutique says.
The company priced an upsized 5.7M shares (up from 5M) at $15, after marketing the range at $14-$16/share.
That marks a raise of $85.5M vs. the planned $75M; that means an enterprise value over $227M.
https://seekingalpha.com/news/3503626-aprea-therapeutics-prices-ipo-midpoint
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.